Mumbai-based Somerset Indus Capital Partners has raised $15 million from Proparco (the private sector arm of Agence Française de Développement Group) for its Somerset Indus Healthcare Fund III, targeting growth stage investments in hospitals, diagnostics, pharmaceuticals, medical devices, and digital health to enhance affordable, quality care in underserved Tier II and Tier III cities.
Glimpse:
The $15 million commitment from Proparco bolsters Fund III (nearing a $250 million close) to bridge India’s “missing middle” healthcare gaps. Somerset’s portfolio already supports 40 hospitals with 4,500 beds, 4,600 professionals, and 5,000 diagnostic facilities across 15 investments. This Indo French collaboration aligns with sustainable development goals and anticipates deeper ties during the 2026 India France Year of Innovation.
Somerset Indus Capital Partners, a leading Mumbai-based healthcare-focused private equity firm, has secured a $15 million investment from Proparco for its third fund, Somerset Indus Healthcare Fund III. This latest infusion, announced in December 2025, underscores growing international confidence in India’s mid market healthcare sector and its potential to deliver impactful, affordable services in underserved regions.
Fund III targets growth stage enterprises across key segments: hospitals, diagnostics, pharmaceuticals, medical devices, and digital health. The focus remains on Tier II and Tier III cities, where access to quality care lags significantly, addressing the needs of India’s “missing middle” millions who fall between basic public services and premium urban facilities.
Proparco’s involvement highlights the strengthening Indo-French partnership in sustainable development. The funding will enable Somerset to scale innovative models that improve affordability, care quality, and accessibility while generating employment and economic opportunities in smaller cities.
Since inception in 2011, Somerset has invested in 15 portfolio companies (eight active), collectively operating 40 hospitals with 4,500 beds, employing over 4,600 healthcare professionals, and managing approximately 5,000 diagnostic facilities. These investments have expanded essential services to millions, demonstrating the firm’s “Capital for Change” philosophy blending strong financial returns with meaningful social impact.
Fund III, which marked progress toward a $250 million target earlier in 2025 with commitments from diverse global investors (including European and US development finance institutions), is poised for further growth. Somerset typically deploys $15–40 million per deal, partnering with first-generation entrepreneurs to catalyze innovation.
This deal arrives amid India’s healthcare evolution, with rising demand for localized, cost-effective solutions in non-metro areas. It also sets the stage for enhanced bilateral cooperation in 2026, designated as the India-France Year of Innovation.
“France and India share a long-standing partnership grounded in innovation and sustainable development. Proparco’s investment in Somerset Indus Fund III strengthens this dynamic by supporting the growth of impactful healthcare companies across India.”
By
HB Team
